Article

Dr. McDonnell testifies about need for more NEI funding

Washington-Advancements in eye research might be in jeopardy unless Congress works to boost the president's recommended National Institutes of Health (NIH) funding levels for fiscal year 2007.

In his proposed budget for next year, President George W. Bush is recommending no increase over the 2006 funding of $28.5 billion for the NIH, with a 0.8% reduction (or $5.3 million) for the National Eye Institute (NEI).

Dr. McDonnell, director and Wilmer Holland Wilmer Professor of Ophthalmology at the Wilmer Eye Institute, the Johns Hopkins University School of Medicine, Baltimore, MD, is chief medical editor of Ophthalmology Times. Sen. Arlen Specter (R-PA), who chairs the subcommittee, had invited about 20 other representatives of NIH-funded institutes to identify the areas that would be hurt by insufficient funding.

Funding 'necessary'

If the president's budget passes, it would be the fourth year that the NIH funding would not keep pace with inflation, according to the National Alliance for Eye and Vision Research (NAEVR). The group is asking Congress to fund the NIH at $29.8 billion-a 5% increase over the 2006 level-with $711 million-a 6% increase over last year-for the NEI.

"This level represents the eye and vision research community's judgment as that level necessary to advance fully the breakthroughs resulting from NEI's basic and clinical research that are resulting in treatments and therapies to prevent eye disease and restore vision," the group said in a prepared statement.

James F. Jorkasky, NAEVR executive director, said researchers stand to lose what was gained during the years the budget was doubled. He is working with other health and education groups to lobby legislators in the House and Senate to increase funding.

In separate budget resolutions, the House and Senate indicated a desire to boost those programs by $7 billion, which would include $1 billion for the NIH budget to restore 2005 funding levels.

"We will continue to impress upon the House and the Senate the importance of an increase for the NIH in fiscal year '07 not only due to the impact of inflation, but the fact that we cannot lose the momentum of discovery that has emerged from the past doubling of the NIH budget," Jorkasky said.

Dr. McDonnell called his 90-second statement before the Senate subcommittee "an interesting and positive experience," which he hopes will help legislators understand the importance of biomedical research.

"The potential savings associated with preventing people from losing central vision as occurs in AMD are enormous, because they need fewer services and are more independent," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.